FAKTOR OPTIONSSCHEIN - BOSTON SCIENTIFIC | Market Closed - BOERSE MUENCHEN 14:25:50 2024-06-14 EDT | ||
| 31.47 EUR | +1.52% |
|
| Current month | +9.27% | ||
| 1 month | +16.21% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 31.47 | +1.52% |
| 24-06-13 | 31 | -2.55% |
| 24-06-12 | 31.81 | +0.76% |
| 24-06-11 | 31.57 | -0.22% |
| 24-06-10 | 31.64 | -0.66% |
Real-time BOERSE MUENCHEN
Last update June 14, 2024 at 02:25 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | Goldman Sachs |
| WKN | GX6B28 |
| ISIN | DE000GX6B282 |
| Date issued | 2021-12-16 |
| Strike | 51.31 $ |
| Maturity | Unlimited |
| Parity | 0.76 : 1 |
| Emission price | 9.98 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 32.75 € |
|---|---|
| Lowest since issue | 5.75 € |
| Spread | 0.3 € |
| Spread % | 0.95% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
76.76
USD
Average target price
82.26
USD
Spread / Average Target
+7.16%
- Stock Market
- Certificates
- Certificat
